Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Magnesium Oxide Tablet 500 Mg

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05774015Not ApplicableCompleted

Effect of Oral Magnesium Supplementation on Type II Diabetes Mellitus Guided by Serum Ionized Magnesium Level

NCT05903677UnknownPrimary

The Relationship Between Preoperative Levels of Ionized Magnesium and Risk of Acute Kidney Injury After Cardiac Surgery

NCT03123796Completed

Effects of Proton Pump Inhibitors on Kidney Transplant Recipients

Showing all 3 trials

Research Network

Common Treatments

  • Magnesium Oxide Tablet 500 Mg1
  • Magnesium Levels1

Active Sponsors

  • Assiut University1
  • Istanbul University1
  • Nova Biomedical1
  • Sultan Qaboos University1

Top Investigators

  • Yasar Caliskan, MD1

    Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine

Related Conditions

  • Transplant Dysfunction1
  • Type 2 Diabetes1

Activity Timeline